Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Influenza Medication market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Influenza Medication market. Detailed analysis of key players, along with key growth strategies adopted by Influenza Medication industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Natco Pharma
Sandoz International GmbH (Novartis AG)
F. Hoffmann-La Roche
GlaxoSmithKline
Mylan
F Hoffmann-La Roche
Teva Pharmaceutical
Daiichi Sankyo Company
By Type:
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other
By End-User:
Hospitals
Clinics
Pharmacies
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Medication Market
-
1.3 Market Segment by Type
1.3.1 Japan Influenza Medication Market Size and Growth Rate of Zanamivir from 2014 to 2026
1.3.2 Japan Influenza Medication Market Size and Growth Rate of Oseltamivir from 2014 to 2026
1.3.3 Japan Influenza Medication Market Size and Growth Rate of Peramivir from 2014 to 2026
1.3.4 Japan Influenza Medication Market Size and Growth Rate of Amantadine from 2014 to 2026
1.3.5 Japan Influenza Medication Market Size and Growth Rate of Rimantadine from 2014 to 2026
1.3.6 Japan Influenza Medication Market Size and Growth Rate of Inosine from 2014 to 2026
1.3.7 Japan Influenza Medication Market Size and Growth Rate of Other from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Influenza Medication Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Japan Influenza Medication Market Size and Growth Rate of Clinics from 2014 to 2026
1.4.3 Japan Influenza Medication Market Size and Growth Rate of Pharmacies from 2014 to 2026
1.4.4 Japan Influenza Medication Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Influenza Medication Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Influenza Medication by Major Types
3.4.1 Market Size and Growth Rate of Zanamivir
3.4.2 Market Size and Growth Rate of Oseltamivir
3.4.3 Market Size and Growth Rate of Peramivir
3.4.4 Market Size and Growth Rate of Amantadine
3.4.5 Market Size and Growth Rate of Rimantadine
3.4.6 Market Size and Growth Rate of Inosine
3.4.7 Market Size and Growth Rate of Other
4 Segmentation of Influenza Medication Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Influenza Medication by Major End-Users
4.4.1 Market Size and Growth Rate of Influenza Medication in Hospitals
4.4.2 Market Size and Growth Rate of Influenza Medication in Clinics
4.4.3 Market Size and Growth Rate of Influenza Medication in Pharmacies
4.4.4 Market Size and Growth Rate of Influenza Medication in Others
5 Market Analysis by Regions
-
5.1 Japan Influenza Medication Production Analysis by Regions
-
5.2 Japan Influenza Medication Consumption Analysis by Regions
6 Hokkaido Influenza Medication Landscape Analysis
-
6.1 Hokkaido Influenza Medication Landscape Analysis by Major Types
-
6.2 Hokkaido Influenza Medication Landscape Analysis by Major End-Users
7 Tohoku Influenza Medication Landscape Analysis
-
7.1 Tohoku Influenza Medication Landscape Analysis by Major Types
-
7.2 Tohoku Influenza Medication Landscape Analysis by Major End-Users
8 Kanto Influenza Medication Landscape Analysis
-
8.1 Kanto Influenza Medication Landscape Analysis by Major Types
-
8.2 Kanto Influenza Medication Landscape Analysis by Major End-Users
9 Chubu Influenza Medication Landscape Analysis
-
9.1 Chubu Influenza Medication Landscape Analysis by Major Types
-
9.2 Chubu Influenza Medication Landscape Analysis by Major End-Users
10 Kinki Influenza Medication Landscape Analysis
-
10.1 Kinki Influenza Medication Landscape Analysis by Major Types
-
10.2 Kinki Influenza Medication Landscape Analysis by Major End-Users
11 Chugoku Influenza Medication Landscape Analysis
-
11.1 Chugoku Influenza Medication Landscape Analysis by Major Types
-
11.2 Chugoku Influenza Medication Landscape Analysis by Major End-Users
12 Shikoku Influenza Medication Landscape Analysis
-
12.1 Shikoku Influenza Medication Landscape Analysis by Major Types
-
12.2 Shikoku Influenza Medication Landscape Analysis by Major End-Users
13 Kyushu Influenza Medication Landscape Analysis
-
13.1 Kyushu Influenza Medication Landscape Analysis by Major Types
-
13.2 Kyushu Influenza Medication Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Natco Pharma
14.1.1 Natco Pharma Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Sandoz International GmbH (Novartis AG)
14.2.1 Sandoz International GmbH (Novartis AG) Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 F. Hoffmann-La Roche
14.3.1 F. Hoffmann-La Roche Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 GlaxoSmithKline
14.4.1 GlaxoSmithKline Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Mylan
14.5.1 Mylan Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 F Hoffmann-La Roche
14.6.1 F Hoffmann-La Roche Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Teva Pharmaceutical
14.7.1 Teva Pharmaceutical Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Daiichi Sankyo Company
14.8.1 Daiichi Sankyo Company Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
The List of Tables and Figures (Totals 84 Figures and 152 Tables)
Figure Japan Influenza Medication Market Size and Growth Rate of Zanamivir from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Oseltamivir from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Peramivir from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Amantadine from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Rimantadine from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Inosine from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Other from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Pharmacies from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Influenza Medication Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Influenza Medication Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Influenza Medication
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Influenza Medication by Different Types from 2014 to 2026
-
Table Consumption Share of Influenza Medication by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Zanamivir
Figure Market Size and Growth Rate of Oseltamivir
Figure Market Size and Growth Rate of Peramivir
Figure Market Size and Growth Rate of Amantadine
Figure Market Size and Growth Rate of Rimantadine
Figure Market Size and Growth Rate of Inosine
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Influenza Medication by Different End-Users from 2014 to 2026
-
Table Consumption Share of Influenza Medication by Different End-Users from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Clinics from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Pharmacies from 2014 to 2026
Figure Japan Influenza Medication Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan Influenza Medication Production by Regions
-
Table Japan Influenza Medication Production Share by Regions
-
Figure Japan Influenza Medication Production Share by Regions in 2014
-
Figure Japan Influenza Medication Production Share by Regions in 2018
-
Figure Japan Influenza Medication Production Share by Regions in 2026
-
Table Japan Influenza Medication Consumption by Regions
-
Table Japan Influenza Medication Consumption Share by Regions
-
Figure Japan Influenza Medication Consumption Share by Regions in 2014
-
Figure Japan Influenza Medication Consumption Share by Regions in 2018
-
Figure Japan Influenza Medication Consumption Share by Regions in 2026
-
Table Hokkaido Influenza Medication Consumption by Types from 2014 to 2026
-
Table Hokkaido Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Influenza Medication Consumption Share by Types in 2014
-
Figure Hokkaido Influenza Medication Consumption Share by Types in 2018
-
Figure Hokkaido Influenza Medication Consumption Share by Types in 2026
-
Table Hokkaido Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Influenza Medication Consumption Share by End-Users in 2014
-
Figure Hokkaido Influenza Medication Consumption Share by End-Users in 2018
-
Figure Hokkaido Influenza Medication Consumption Share by End-Users in 2026
-
Table Tohoku Influenza Medication Consumption by Types from 2014 to 2026
-
Table Tohoku Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Influenza Medication Consumption Share by Types in 2014
-
Figure Tohoku Influenza Medication Consumption Share by Types in 2018
-
Figure Tohoku Influenza Medication Consumption Share by Types in 2026
-
Table Tohoku Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Tohoku Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Influenza Medication Consumption Share by End-Users in 2014
-
Figure Tohoku Influenza Medication Consumption Share by End-Users in 2018
-
Figure Tohoku Influenza Medication Consumption Share by End-Users in 2026
-
Table Kanto Influenza Medication Consumption by Types from 2014 to 2026
-
Table Kanto Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Kanto Influenza Medication Consumption Share by Types in 2014
-
Figure Kanto Influenza Medication Consumption Share by Types in 2018
-
Figure Kanto Influenza Medication Consumption Share by Types in 2026
-
Table Kanto Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Kanto Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Influenza Medication Consumption Share by End-Users in 2014
-
Figure Kanto Influenza Medication Consumption Share by End-Users in 2018
-
Figure Kanto Influenza Medication Consumption Share by End-Users in 2026
-
Table Chubu Influenza Medication Consumption by Types from 2014 to 2026
-
Table Chubu Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Chubu Influenza Medication Consumption Share by Types in 2014
-
Figure Chubu Influenza Medication Consumption Share by Types in 2018
-
Figure Chubu Influenza Medication Consumption Share by Types in 2026
-
Table Chubu Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Chubu Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Influenza Medication Consumption Share by End-Users in 2014
-
Figure Chubu Influenza Medication Consumption Share by End-Users in 2018
-
Figure Chubu Influenza Medication Consumption Share by End-Users in 2026
-
Table Kinki Influenza Medication Consumption by Types from 2014 to 2026
-
Table Kinki Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Kinki Influenza Medication Consumption Share by Types in 2014
-
Figure Kinki Influenza Medication Consumption Share by Types in 2018
-
Figure Kinki Influenza Medication Consumption Share by Types in 2026
-
Table Kinki Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Kinki Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Influenza Medication Consumption Share by End-Users in 2014
-
Figure Kinki Influenza Medication Consumption Share by End-Users in 2018
-
Figure Kinki Influenza Medication Consumption Share by End-Users in 2026
-
Table Chugoku Influenza Medication Consumption by Types from 2014 to 2026
-
Table Chugoku Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Influenza Medication Consumption Share by Types in 2014
-
Figure Chugoku Influenza Medication Consumption Share by Types in 2018
-
Figure Chugoku Influenza Medication Consumption Share by Types in 2026
-
Table Chugoku Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Chugoku Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Influenza Medication Consumption Share by End-Users in 2014
-
Figure Chugoku Influenza Medication Consumption Share by End-Users in 2018
-
Figure Chugoku Influenza Medication Consumption Share by End-Users in 2026
-
Table Shikoku Influenza Medication Consumption by Types from 2014 to 2026
-
Table Shikoku Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Influenza Medication Consumption Share by Types in 2014
-
Figure Shikoku Influenza Medication Consumption Share by Types in 2018
-
Figure Shikoku Influenza Medication Consumption Share by Types in 2026
-
Table Shikoku Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Shikoku Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Influenza Medication Consumption Share by End-Users in 2014
-
Figure Shikoku Influenza Medication Consumption Share by End-Users in 2018
-
Figure Shikoku Influenza Medication Consumption Share by End-Users in 2026
-
Table Kyushu Influenza Medication Consumption by Types from 2014 to 2026
-
Table Kyushu Influenza Medication Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Influenza Medication Consumption Share by Types in 2014
-
Figure Kyushu Influenza Medication Consumption Share by Types in 2018
-
Figure Kyushu Influenza Medication Consumption Share by Types in 2026
-
Table Kyushu Influenza Medication Consumption by End-Users from 2014 to 2026
-
Table Kyushu Influenza Medication Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Influenza Medication Consumption Share by End-Users in 2014
-
Figure Kyushu Influenza Medication Consumption Share by End-Users in 2018
-
Figure Kyushu Influenza Medication Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Natco Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Natco Pharma
Figure Sales and Growth Rate Analysis of Natco Pharma
Figure Revenue and Market Share Analysis of Natco Pharma
Table Product and Service Introduction of Natco Pharma
Table Company Profile and Development Status of Sandoz International GmbH (Novartis AG)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH (Novartis AG)
Figure Sales and Growth Rate Analysis of Sandoz International GmbH (Novartis AG)
Figure Revenue and Market Share Analysis of Sandoz International GmbH (Novartis AG)
Table Product and Service Introduction of Sandoz International GmbH (Novartis AG)
Table Company Profile and Development Status of F. Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche
Table Product and Service Introduction of F. Hoffmann-La Roche
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Mylan
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
Figure Sales and Growth Rate Analysis of Mylan
Figure Revenue and Market Share Analysis of Mylan
Table Product and Service Introduction of Mylan
Table Company Profile and Development Status of F Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche
Table Product and Service Introduction of F Hoffmann-La Roche
Table Company Profile and Development Status of Teva Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
Table Product and Service Introduction of Teva Pharmaceutical
Table Company Profile and Development Status of Daiichi Sankyo Company
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Company
Figure Sales and Growth Rate Analysis of Daiichi Sankyo Company
Figure Revenue and Market Share Analysis of Daiichi Sankyo Company
Table Product and Service Introduction of Daiichi Sankyo Company
-
